Nutural Plant Extract 50%~98% Amygdalin (Vitamin B17) Factory Supply

• Customization: Available
• Certification: ISO, HACCP
• Assay Method: HPLC
• Application Form: Tablet, Capsule
• Application: Food, Health Care Products, Medicine
• State: Powder
• Extract Source: Bitter Apricot Extract
• Spec: 50%~98%
• Transport Package: Drum
• Specification: 25 Kg/drum
• Origin: China

Product Description

Nutural Plant Extract 50%~98% Amygdalin (Vitamin B17) Factory Supply



Product description

Product Name	Amygdalin(Vitamin B17)
Botanical Resource	Prunus Armeniaca L
Part of the Plant Used	Seed (Dried 100% Natural)
Active Ingredients	Amygdalin
CAS No.	29883-15-6
Molecular Formula	C20H27O11
Molecular Weight	457.44
Product Spec	Amygdalin 50%~98%

Product Introduction
Amygdalin, also known as Vitamin B17 or laetrile, is a substance found naturally in the seeds of many kinds of fruits, such as plums, cherries, oranges, nectarines, apples and peaches, particularly in the apricot pits and bitter almonds. These are all highly nutritious foods with chemical contents that provide an excellent range of important benefits for the human body. As a result, many people have begun to call amygdalin 'vitamin B17'. Amygdalin was first discovered and isolated by two French chemists in the early 1800s.Preclinical studies by the U.S. government's National Institutes of Health using laetrile alone and in combination with other substances showed little evidence that it is effective against cancer. In 1924, laetrile was synthesized from amygdalin and promoted as a cancer treatment. Laetrile continued to gain popularity. Some doctors believe that laetrile can help to relieve the pain of cancer. One theory is that cancer cells contain large quantities of the enzyme beta-glucosidase. This enzyme breaks the amygdalin down and releases cyanide, a toxic chemical that then kills cancer cells. Laetrile is a compound that has been used as an anticancer treatment in humans worldwide. Research also find Amygdalin may play partial protective role in hyperoxia-induced lung injury. In 1980, the National Cancer Institute began a study to evaluate the use of laetrile in cancer patients. Although some patients reported that they felt better while taking laetrile, the cancer continued to progress in all patients so concluded that further research into laetrile was not warranted. The drug is made and used as a cancer treatment in Mexico.

HPLC Chromatogram of Bitter Apricot Seed Extract 98% Amygdalin



Applications
Pharmaceutical stuff

Company Scene